Software & SaaS

With a novel 'NewCo' model and key partnerships, Banyan BioInnovations aims to de-risk and accelerate clinical-stage drugs past the funding valley of death.

A new wave of AI builds entire enterprise apps, but can it be trusted? WaveMaker's early success suggests its architecture-first approach is the key.

A new partnership moves AI from isolated tasks to integrated workflows, promising to solve the ROI problem that has plagued enterprise adoption.

Beijing has placed AI-powered robots at the core of its national strategy, aiming to reshape global manufacturing and accelerate a new technological race.

A new partnership aims to tackle AI's biggest security risks, signaling a major industry shift from functional AI to production-ready, secure AI.

As acquisition costs soar, Fast Simon hires a partnership director to arm agencies with AI tools, turning on-site traffic into much-needed revenue.

The 2026 Ellis Island Medals of Honor recipients are announced, celebrating leaders from OpenAI, Mercedes-Benz, and more for their global impact.

GMEX Robotics' first deployment of its Bon Vivant 3.0 cooking robots marks a new era for Australia's hospitality industry, blending AI with culinary arts.

JAGGAER launches JAI, an AI assistant promising to slash support tickets and automate complex buying decisions, pushing procurement toward an autonomous future.

Arctera shifts to a unified SaaS model, promising limitless scale for data compliance. What does this strategic pivot mean for enterprises and the market?

NImmune Biopharma's oral drug NIM-1324 shows promising safety and efficacy, targeting a novel pathway to treat IBD and a host of other diseases.

With 21% of voice actors reporting job losses to AI, a national association is taking its fight to D.C. to demand policy action and protect human creativity.

With compliance costs soaring, Spring Labs' $5M funding round will scale its AI agents to automate the execution of regulatory tasks for financial firms.

Forrester's new report highlights Airia as enterprises grapple with governing the new wave of autonomous, agentic AI systems that defy old rules.

A historic 142 deals and $1.67 trillion in assets changed hands in Q1 2026, as private equity, tech, and global ambitions fuel a record consolidation wave.

A new partnership offers employees interest-free financing for out-of-pocket medical costs, tackling a key barrier to care and boosting employer benefits.

Maine's tourism office is using AI to create personalized trip plans, guiding visitors to hidden gems and boosting local economies across the Pine Tree State.

A new national agreement brings QuVa Pharma's AI-powered drug diversion software to thousands of hospitals, promising a high-tech solution to a hidden crisis.

Viant's acquisition of TVision challenges industry giants by pricing TV ads on actual viewership, moving beyond impressions to verifiable human attention.

A new blood test could tell you if GLP-1 drugs will work for you before you start, a major leap for precision medicine in the booming obesity market.